GKOS
Glaukos Corporation
Medical Devices · Healthcare · United States
242.48
close · 2026-10-29
value
1
cheaper than peers1
quality
73
stronger fundamentals73
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 17.46× | 9 |
| price to book | 21.25× | 6 |
| forward P/E | 243.91× | 6 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 49.5% | 97 |
| debt to equity | 15.8% | 70 |
| operating margin | -8.5% | 43 |
| return on equity | -26.0% | 41 |
4 of 4 measures available
Facts
| market cap | $14B |
| free cash flow | $15.5M |
| employees | 1,094 |
| first trade | 2015-06-25 |
| next earnings | 2026-10-28 |
| fundamentals updated | 2026-10-28 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -3.28 | -2.77 | -2.78 | -2.09 |
| free cash flow | -$39.1M | -$67.6M | -$78.0M | -$63.3M |
| net income | -$187.7M | -$146.4M | -$134.7M | -$99.2M |
| revenue | $507.4M | $383.5M | $314.7M | $282.9M |
| unusual items | $0 | -$14.2M | -$5.0M | $20.0M |